Sale Date Ended
Life Science Conclave 2011
Enabling Growth Through Collaborative R&D And Technology Transfer
1.Who are the target audience?
Three previous versions of Life Science Conclave (LSC) have witnessed a attendance of 300-400 delegates with around 150 decision makers visiting the event and looking for their suitable partners.
2. What types of organizations are expected to join?
CII has most of big Pharma and life sciences organizations as our members in addition to Pharma and life sciences SME’s, Medical Device Organizations, Pharmaceutical Suppliers, Consulting organizations, KPO/BPO’s, who will join this event.
3.How successful the event has been so far?
LSC has been a grand success in terms of the kind of decision makers/professionals we bring on board as speakers, kind of organizations who represent themselves in the event, kind of delegates who make their presence felt in the event and at the end of it the kind of valued B2B/B2G meetings, which take place to facilitate the business. This year also, we are organizing the LSC in the way that not only inherit the mentioned features from previous editions of LSC but also get synergistic effects from components like CSO/CTO Conference and Research & Technology disposition.
4.What benefits it can bring to us on participation and why should we invest in it?
LSC is a platform for deliberation on some of the concerning issues hindering the growth of life sciences in India, and showcase of the leading products, services and technologies in life sciences that are being researched and developed in India; and because Delhi is hub for Bureaucrats, LSC draws a great amount of attention from the right stakeholders from Govt of India; This is no ordinary showcase! The event therefore attracts decision makers from global pharma and big biotech - executives keen to get first sight of the latest developments from across the globe. We deliberately keep the LSC event small in terms of numbers of delegates - typically no more than 400 in total. This provides an environment conducive to informal networking (you'll never have the problem of not being able to find someone!) and it means we maintain the quality of the event in terms of the type of company attending (we focus mainly on the bio-pharma companies) in addition to the seniority of delegate. I think with this as a reference, it will be a second to none platform for the organization like yours to participate in this event and make your quality presence felt among the desired professionals and organizations.
The conclave will highlight the modalities to maximize the value of intellectual property developed at the industry level by identifying, protecting and commercializing discoveries and inventions to save lives,
improve the quality of life to benefit the consumers. The session will also focus on economic development of the local community by effective Technology Transfer.